C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor

Patents for C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor (182,629)
08/2011
08/25/2011	US20110209229 Gene of porcine beta casein, a promoter of the same and the use thereof
08/25/2011	US20110209228 Method of treatment using antimicrobial composition
08/25/2011	US20110208673 Antibodies to lymphotoxin-alpha
08/25/2011	US20110208162 Methods for preventing aggregation of adipose stromal cells
08/25/2011	US20110207912 Fgf-19 nucleic acids
08/25/2011	US20110207911 Polypeptide derived from the ryanodine receptor that inhibits calcium leakage
08/25/2011	US20110207816 Alternate morpheeins of allosteric proteins as a target for the development of bioactive molecules
08/25/2011	US20110207801 Novel Genes, Compositions, and Methods for Modulating the Unfolded Protein Response
08/25/2011	US20110207800 HIV-Dependent expression constructs and uses therefore
08/25/2011	US20110207796 Alpha-synuclein kinase
08/25/2011	US20110207730 Ion channel modulating compounds and uses thereof
08/25/2011	US20110207686 Polysaccharide-and polypeptide-based block copolymers, vesicles constituted by these copolymers and use thereof
08/25/2011	US20110207677 Use of Cell-Permeable Peptide Inhibitors of the JNK Signal Transduction Pathway for the Treatment of Chronic or Non-Chronic Inflammatory Digestive Diseases
08/25/2011	US20110207675 Gene fusion targeted therapy
08/25/2011	US20110207669 Recombinant proteins having haemostatic activity and capable of inducing platelet aggregation
08/25/2011	US20110207664 Materials and Methods Involving Hybrid Vascular Endothelial Growth Factor DNAs and Proteins
08/25/2011	US20110207663 Fibroblast growth factor (fgf) analogs and uses thereof
08/25/2011	US20110207656 MUC1, CASPASE-8, and DED-CONTAINING PROTEINS
08/25/2011	US20110207625 Pirna and uses related thereto
08/25/2011	US20110207608 Transcriptional and post-transcription regulation of transcription factor for drought resistance
08/25/2011	US20110207224 In vivo production of small interfering rnas that mediate gene silencing
08/25/2011	US20110207223 Methods of generating alphavirus particles
08/25/2011	US20110207222 Methods and Systems For Manipulating Particles Using a Fluidized Bed
08/25/2011	US20110207220 Cell pattern recovery tool
08/25/2011	US20110207219 Modified substrates for protection of peptide-immobilized surfaces from gamma radiation degradation
08/25/2011	US20110207218 Mixing system with condenser
08/25/2011	US20110207217 Modulation of Gene Expression by Oligomers Targeted to Chromosomal DNA
08/25/2011	US20110207216 Synthetic Peptide (Meth) Acrylate Microcarriers
08/25/2011	US20110207215 Cell storage method and cell transport method
08/25/2011	US20110207214 Novel tools for the production of glycosylated proteins in host cells
08/25/2011	US20110207213 Photoreactive Synthetic Regulator of Protein Function and Methods of Use Thereof
08/25/2011	US20110207212 T1r taste receptors and genes encoding same
08/25/2011	US20110207211 Expression of immunoglobulin-cytokine fusion proteins in malignant b cells
08/25/2011	US20110207198 Compositions and methods for inhibiting mmset
08/25/2011	US20110207186 Isoforms of Pig Liver Esterase
08/25/2011	US20110207181 Isomaltulose synthases, polynucleotides encoding them and uses therefor
08/25/2011	US20110207174 Peptide-containing culture medium for culturing animal cell
08/25/2011	US20110207167 Method of isolating a cell from urine
08/25/2011	US20110207166 Human bone marrow microenvironments and uses thereof
08/25/2011	US20110207165 Small scale shaker flask cultivation
08/25/2011	US20110207148 T1r hetero-oligomeric taste receptors and cell lines that express said receptors and use thereof for identification of taste compounds
08/25/2011	US20110207147 Compositions and Methods for Modification of Biomolecules
08/25/2011	US20110207133 Binding and functional assays that use the t1r3 receptor to screen for taste modulatory compounds
08/25/2011	US20110207124 Genetic Alterations Associated with Autism and the Autistic Phenotype and Methods of Use Thereof for the Diagnosis and Treatment of Autism
08/25/2011	US20110207117 Generation of production strains that efficiently express nuclear transgenes
08/25/2011	US20110207116 Spatio-temporal control of protein interactions using phytochromes
08/25/2011	US20110207112 Automated system for cryopreservation of oocytes, embryos, or blastocysts
08/25/2011	US20110206784 Composition for the prevention and treatment of postmenopausal syndrome containing extracts or fractions of aceriphyllum rossii as an effective ingredient
08/25/2011	US20110206781 Method to modulate hematopoietic stem cell growth
08/25/2011	US20110206759 Ccr7 ligand delivery and co-delivery in immunotherapy
08/25/2011	US20110206755 Methods and products for manipulating uncoupling protein expression
08/25/2011	US20110206740 Cell Membrane Engineering
08/25/2011	US20110206735 Tumorigenic CancerStemCells, Methods of Isolating and Using the Same
08/25/2011	US20110206734 Hybrid scfa-hydroxyl-derivatized monosaccharides, methods of synthesis, and methods of treating disorders
08/25/2011	US20110206724 Hepatitis virus core proteins as vaccine platforms and methods of use thereof
08/25/2011	US20110206720 Anti-inflammatory usage of antrodia cinnamomea fruit body derivatives
08/25/2011	US20110206711 Method for inducing cytotoxic t-cells, cytotoxic t-cell inducer, and pharmaceutical composition and vaccine employing same
08/25/2011	US20110206710 Recombinant lentiviral vector for expression of a flaviviridae protein and applications thereof as a vaccine
08/25/2011	US20110206708 Method for stimulating a therapeutic immune effect in a patient
08/25/2011	US20110206707 Method for stimulating a host immune system
08/25/2011	US20110206702 Compositions and methods for the diagnosis and treatment of tumor
08/25/2011	US20110206700 Anti-cd33 antibodies and methods for treatment of acute myeloid leukemia using the same
08/25/2011	US20110206698 Antagonist anti-il-7 receptor antibodies and methods
08/25/2011	US20110206697 Spink1 targeted therapy
08/25/2011	US20110206688 Enhancing Vessel Lesion Homing and Repair Potential of Stem Cells
08/25/2011	US20110206686 Il-23 antibodies
08/25/2011	US20110206683 Preservation mixture and use thereof
08/25/2011	US20110206682 Monoclonal antibodies, synthetic and biotechnological derivatives thereof acting as ngf-antagonist molecules
08/25/2011	US20110206681 Binding molecules to the human ox40 receptor
08/25/2011	US20110206678 Antibodies Specific for Sclerostin and Methods for Increasing Bone Mineralization
08/25/2011	US20110206677 Antibodies specific for sclerostin and methods for increasing bone mineralization
08/25/2011	US20110206675 Anti-notch3 agonist antibodies and their use in the treatment of notch3-related diseases
08/25/2011	US20110206673 Polypeptides and polynucleotides for artemin and related ligands, and methods of use thereof
08/25/2011	US20110206663 Anti-Interferon-Alpha Antibodies
08/25/2011	US20110206660 Amino acid sequences directed against cxcr4 and other gpcrs and compounds comprising the same
08/25/2011	US20110206658 Compositions and methods for the treatment of tumor of hematopoietic origin
08/25/2011	US20110206657 Antibodies binding to an intracellular prl-1 or prl-3 polypeptide
08/25/2011	US20110206655 Fviii-independent fix-mutant proteins for hemophilia a treatment
08/25/2011	US20110206648 Gene-enhanced tissue engineering
08/25/2011	US20110206647 Modulation of Angiogenesis
08/25/2011	US20110206645 Treatment of bone-related cancers using placental stem cells
08/25/2011	US20110206644 Methods for trans-differentiating cells
08/25/2011	US20110206643 Automated Cell Therapy System
08/25/2011	US20110206639 Replication competent viruses capable of silencing virus inhibitory factor expression
08/25/2011	US20110206638 Compositions and methods for reducing the mutation rate of viruses
08/25/2011	US20110206616 Recombinant derivatives of botulinum neurotoxins engineered for trafficking studies and neuronal delivery
08/25/2011	US20110206607 Imidazol (1,2-a)pyridines and related compounds with activity at cannabinoid cb2 receptors
08/25/2011	CA2790436A1 Immunocompatible chorionic membrane products
08/25/2011	CA2790340A1 Methods of manufacture of therapeutic products comprising vitalized placental dispersions
08/25/2011	CA2790336A1 Therapeutic products comprising vitalized placental dispersions
08/25/2011	CA2790325A1 Immunocompatible amniotic membrane products
08/25/2011	CA2790322A1 Methods of manufacture of immunocompatible chorionic membrane products
08/25/2011	CA2790299A1 Cell culture medium for the growth and differentiation of cells of the hematopoietic lineage
08/25/2011	CA2790290A1 Antibody against serotype g lipopolysaccharide of pseudomonas aeruginosa
08/25/2011	CA2790289A1 Antibody against serotype b lipopolysaccharide of pseudomonas aeruginosa
08/25/2011	CA2790276A1 Antibody against serotype a lipopolysaccharide of pseudomonas aeruginosa
08/25/2011	CA2790232A1 Antibody against serotype i lipopolysaccharide of pseudomonas aeruginosa
08/25/2011	CA2790228A1 Antibody against serotype e lipopolysaccharide of pseudomonas aeruginosa
08/25/2011	CA2790134A1 Pd-1 modulation and uses thereof for modulating hiv replication
08/25/2011	CA2790029A1 Axmi221z, axmi222z, axmi223z, axmi224z, and axmi225z delta-endotoxin genes and methods for their use

1 ... 336 337 338 339 340 341 342 343 344 345 346 347 348 349 350 351 352 353 354 355 356 ... 1827